Nothing Special   »   [go: up one dir, main page]

CN108947995B - Preparation method of polysubstituted oxadiazine derivative - Google Patents

Preparation method of polysubstituted oxadiazine derivative Download PDF

Info

Publication number
CN108947995B
CN108947995B CN201811079843.XA CN201811079843A CN108947995B CN 108947995 B CN108947995 B CN 108947995B CN 201811079843 A CN201811079843 A CN 201811079843A CN 108947995 B CN108947995 B CN 108947995B
Authority
CN
China
Prior art keywords
reaction
substituted
polysubstituted
preparation
nmr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201811079843.XA
Other languages
Chinese (zh)
Other versions
CN108947995A (en
Inventor
李明
李卫
文丽荣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shoujian Technology Co ltd
Original Assignee
Qingdao University of Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qingdao University of Science and Technology filed Critical Qingdao University of Science and Technology
Priority to CN201811079843.XA priority Critical patent/CN108947995B/en
Publication of CN108947995A publication Critical patent/CN108947995A/en
Application granted granted Critical
Publication of CN108947995B publication Critical patent/CN108947995B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Steroid Compounds (AREA)

Abstract

The invention discloses a preparation method of a polysubstituted oxadiazine derivative, belonging to the technical field of organic synthesis. The method comprises the following steps: and (2) adding substituted benzylaminoxime, substituted phenylethynyl iodonium salt and potassium hydroxide into a reaction container in sequence, adding a solvent tetrahydrofuran, stirring at room temperature until the reaction is finished for 4 hours, concentrating the filtrate by using a rotary evaporator to obtain a crude product, and performing chromatographic separation on the crude product by using a silica gel column to obtain the target compound. The synthesis method of the oxadiazine derivative provided by the invention has the characteristics of being scientific and reasonable, simple, mild in reaction condition, easy to purify the product and the like. The reaction equation is as follows:

Description

Preparation method of polysubstituted oxadiazine derivative
Technical Field
The invention belongs to the technical field of organic synthesis, and particularly relates to a preparation method of a polysubstituted oxadiazine derivative.
Background
Oxadiazines are one of the less sought after heterocyclic compounds containing N, O and are present in natural products as well as in biologically active molecules. It is used as gamma-secretase regulator and can be used for treating Alzheimer disease. ((a) J.org.chem.2017,82,2957-2964.(b) J.Med.chem.2001,44,619.)
Meanwhile, the document reports that the oxadiazine derivative has important functions in the aspects of pesticides and plant growth regulation. (Chemistry Of Heterocyclic Compounds.2017,53(5), 495-
In view of the wide biological activity and application value of the oxadiazine derivative, the development of a novel method for practically and effectively synthesizing the polysubstituted oxadiazine derivative is of great significance.
In recent years, the preparation of polysubstituted oxadiazine derivatives has been carried out by:
1) in 2006, the Cho subject group developed a 1,2, 4-oxadiazine compound which is synthesized by two steps starting from oxime and taking scandium trifluoromethanesulfonate as a catalyst. (Tetrahedron letters.2006,47, 9029-
2) In 2017, an oxadiazine derivative is developed by a Matthew G.Burscavich subject group through multi-step reaction starting from amide. (J.Med.chem.2017,60,2383-
The above-mentioned process for the preparation of polysubstituted oxadiazine derivatives has certain drawbacks: 1) a multi-step reaction is required, and the final yield is low; 2) some metal catalysts are used; 3) the reaction time is long.
Disclosure of Invention
In order to overcome the defects of the prior art, the invention provides a preparation method of a polysubstituted oxadiazine derivative as a supplement to a synthesis method of a conventional oxadiazine derivative.
A process for the preparation of a polysubstituted oxadiazine derivative having the structure shown in formula i:
Figure BDA0001801644990000021
R1the substituent group is selected from fluorine, chlorine, bromine, iodine, ester group and phenyl; r2The substituent group is selected from fluorine, chlorine and bromine; the method is characterized in that substituted benzamidoxime, substituted phenylethynyl iodonium salt and alkali are added into a reactor, after the reaction in a solvent is completed by stirring, a rotary evaporator is used for concentrating to obtain a crude product, the crude product is separated by silica gel column chromatography to obtain a target product, and the chemical process is shown in a reaction formula II:
Figure BDA0001801644990000022
the molar ratio of the substituted benzamidoxime to the substituted phenylethynyl periodate to the potassium hydroxide is 1:1.2: 1.5. The solvent is tetrahydrofuran, the reaction temperature is room temperature, and the reaction time is 4 h.
The invention has the beneficial effects that: the synthesis method of the polysubstituted oxadiazine derivative provided by the invention is scientific and reasonable, provides a new way, and obtains products with various substituent groups through the method, and is characterized in that: easy obtaining of raw materials, simple operation, mild reaction conditions, short reaction time and the like.
Drawings
FIG. 1 is an NMR spectrum of compound 3aa prepared in example 1;
FIG. 2 is an NMR spectrum of compound 3da prepared in example 4;
FIG. 3 is an NMR spectrum of Compound 3ac prepared in example 7.
Detailed Description
The invention is described in further detail below with reference to the following figures and specific examples:
the test methods described in the following examples are all conventional methods unless otherwise specified; the reagents and materials are commercially available, unless otherwise specified.
Example 1
1) Preparation of oxadiazine derivative 3aa
Figure BDA0001801644990000031
A10 mL round-bottom flask was charged with benzamidoxime 1a (0.3mmol,40.8mg), 2a (0.36mmol,125.3mg) and KOH (0.45mmol,25.2 mg). Tetrahydrofuran (3mL) was added, and the mixture was stirred at room temperature to react for 4 hours. After the reaction was completed, the solvent was removed by using a rotary evaporator to obtain a crude product, which was separated by column chromatography (200-mesh 300-mesh silica gel) (petroleum ether/ethyl acetate: 3/1), and the solvent was removed by using a rotary evaporator to obtain the target product 3aa with a yield of 77%.
Spectrum analysis data 3aa:
1H NMR(500MHz,DMSO-d6)δ8.00(s,1H),7.86(d,1H),7.81(d,J=6.4Hz,2H),7.75(d,J=6.9Hz,2H),7.56–7.43(m,5H),7.39(d,J=7.2Hz,2H),7.30–7.20(m,4H),7.18–7.09(m,3H),6.97(d,J=7.2Hz,2H),4.42–4.32(m,1H),3.58(d,J=12.9Hz,1H).13C NMR(125MHz,DMSO-d6)δ152.97,142.25,135.11,134.18,133.34,132.02,130.95,130.15,129.00,128.57,128.24,128.01,127.48,127.09,126.84,125.83,124.57,116.24,101.13,44.41.HRMS(ESI)m/z calcd for C30H25N4O2 +(M+H)+473.1978,found 473.1974.
example 2
1a in example 1 is replaced by 1b, other conditions are the same as example 1, and the experimental results are shown in Table 1.
Figure BDA0001801644990000041
Spectrogram analysis data 3ba:
1H NMR(500MHz,DMSO-d6)δ8.03(d,J=5.1Hz,1H),7.84(dd,J=8.5,5.5Hz,2H),7.76–7.71(m,3H),7.50(dd,J=8.5,5.7Hz,2H),7.36(dt,J=19.5,8.2Hz,4H),7.25–7.15(m,4H),7.05(dt,J=12.6,8.3Hz,4H),4.40(dd,J=13.1,5.8Hz,1H),3.58(d,J=13.0Hz,1H).13C NMR(125MHz,DMSO-d6)δ152.07,135.10,134.10,130.32,129.66,129.17,129.12,129.02,128.38,128.12,125.88,125.59,124.59,116.03(d,J=15.5Hz),115.80,115.23(d,J=21.0Hz),44.16.HRMS(ESI)m/z calcd for C30H23F2N4O2 +(M+H)+509.1789,found 509.1789.
example 3
1a in example 1 is replaced by 1c, other conditions are the same as in example 1, and the experimental results are shown in Table 1.
Figure BDA0001801644990000051
Spectrogram analysis data 3ca:
1H NMR(500MHz,DMSO-d6)δ8.05(d,J=4.9Hz,1H),7.77(d,J=8.4Hz,2H),7.71(d,J=7.7Hz,2H),7.67(s,1H),7.58–7.49(m,4H),7.37(t,J=7.6Hz,2H),7.28(d,J=8.4Hz,2H),7.23(t,J=7.3Hz,4H),7.07(t,J=7.7Hz,2H),4.41(dd,1H),3.57(d,J=13.1Hz,1H).13C NMR(125MHz,DMSO-d6)δ151.86,141.34,135.64,135.32,133.98,133.65,133.16,130.66,130.41,129.01,128.45,128.37,128.20,127.79,127.22,125.94,124.60,116.24,101.51,44.08.HRMS(ESI)m/z calcd for C30H23Cl2N4O2 +(M+H)+541.1198,found 541.1196.
example 4
1a in example 1 is replaced by 1d, other conditions are the same as in example 1, and the experimental results are shown in Table 1.
Figure BDA0001801644990000052
Spectrogram analysis data 3da:
1H NMR(500MHz,DMSO-d6)δ8.09(d,J=5.3Hz,1H),7.74–7.68(m,6H),7.66(s,1H),7.47(d,J=8.6Hz,2H),7.43(d,J=8.6Hz,2H),7.38(t,J=7.7Hz,2H),7.27–7.22(m,4H),7.09(t,J=7.8Hz,2H),4.43(dd,J=13.2,5.9Hz,1H),3.58(d,J=13.1Hz,1H).13C NMR(125MHz,DMSO-d6)δ151.92,141.42,135.38,133.87(d,J=27.6Hz),131.86,131.15(d,J=32.3Hz),130.42,129.13(d,J=29.9Hz),128.42(d,J=52.4Hz),127.22,125.96,124.51(d,J=23.2Hz),121.87,116.22,101.58,44.11.HRMS(ESI)m/z calcd for C30H23Br2N4O2 +(M+H)+629.0188,found 629.0182.
example 5
1a in example 1 is replaced by 1e, other conditions are the same as in example 1, and the experimental results are shown in Table 1.
Figure BDA0001801644990000061
Spectrogram analysis data 3ea:
1H NMR(500MHz,DMSO-d6)δ8.04(d,J=5.1Hz,1H),7.86(d,J=8.5Hz,2H),7.73–7.68(m,2H),7.64–7.58(m,3H),7.52(d,J=8.5Hz,2H),7.40–7.32(m,4H),7.29–7.22(m,4H),7.13–7.07(m,2H),4.41(dd,J=13.3,5.9Hz,1H),3.56(d,J=12.7Hz,1H).13C NMR(125MHz,DMSO-d6)δ152.14,141.66,137.76,137.19,135.41,134.03,133.90,131.39,130.47,129.27,129.07,128.57,128.52,128.29,127.28,126.03,124.65,116.26,101.65,98.12,95.09,44.17.HRMS(ESI)m/z calcd for C30H23F2N4O2 +(M+H)+724.9910,found 724.9909.
example 6
2a in example 1 is replaced by 2b, other conditions are the same as in example 1, and the experimental results are shown in Table 1.
Figure BDA0001801644990000071
Spectrum analysis data 3ab:
1H NMR(500MHz,DMSO-d6)δ8.03(d,J=5.3Hz,1H),7.87(s,1H),7.86–7.79(m,4H),7.56–7.49(m,3H),7.44(dd,J=6.5,2.9Hz,2H),7.31–7.27(m,3H),7.21(t,J=8.8Hz,2H),7.12(dd,J=8.7,5.4Hz,2H),6.75(t,J=8.8Hz,2H),4.42(dd,J=13.1,5.9Hz,1H),3.60(d,J=13.0Hz,1H).13C NMR(125MHz,DMSO-d6)δ163.10(d,J=246.5Hz),161.59(d,J=242.4Hz),153.03,142.30,134.36,131.98,130.99,130.72,129.50,128.97,128.84,128.69,128.22,127.43,126.91,126.56,116.25,115.82(d,J=21.3Hz),114.81(d,J=21.5Hz),100.75,44.05.HRMS(ESI)m/z calcd for C30H23F2N4O2 +(M+H)+509.1789,found 509.1784.
example 7
2a in example 1 was replaced by 2c, and the experimental results are shown in Table 1, except that the conditions were the same as in example 1.
Figure BDA0001801644990000072
Spectrogram analysis data 3ac:
1H NMR(500MHz,DMSO-d6)δ8.04(d,J=5.3Hz,1H),7.92(s,1H),7.85–7.78(m,4H),7.56–7.49(m,3H),7.45–7.37(m,4H),7.29(t,J=6.2Hz,3H),7.05(d,J=8.6Hz,2H),6.95(d,J=8.5Hz,2H),4.40(dd,J=13.1,5.8Hz,1H),3.58(d,J=13.0Hz,1H).13C NMR(125MHz,DMSO-d6)δ153.13,142.52,135.17,134.08,133.05,131.98,131.41,131.02,128.98,128.80,128.73,128.18,127.94,127.69,127.51,126.94,126.36,116.88,100.83,43.87.HRMS(ESI)m/z calcd for C30H23Cl2N4O2 +(M+H)+541.1198,found 541.1196.
example 8
2a in example 1 is replaced by 2d, other conditions are the same as in example 1, and the experimental results are shown in Table 1.
Figure BDA0001801644990000081
Spectrogram analysis data 3ad:
1H NMR(500MHz,DMSO-d6)δ8.05(d,J=5.3Hz,1H),7.93(s,1H),7.85–7.81(m,2H),7.74(d,J=8.4Hz,2H),7.53(ddd,J=19.6,10.5,5.2Hz,5H),7.41–7.37(m,2H),7.30(q,J=6.8,6.1Hz,3H),4.39(dd,J=13.1,5.8Hz,1H),3.59(d,J=13.1Hz,1H).13C NMR(125MHz,DMSO-d6)δ153.15,142.58,134.13,133.44,132.44,131.95,131.88,131.00,130.88,128.96,128.80,128.76,128.17,127.90,127.54,126.92,126.70,124.03,119.88,116.89,100.96,43.87.HRMS(ESI)m/z calcd for C30H23Br2N4O2 +(M+H)+629.0188,found 629.0181.
example 9
1f is used instead of 1a in example 6, the conditions are the same as in example 1, and the experimental results are shown in Table 1.
Figure BDA0001801644990000091
Spectrogram analysis data 3fb:
1H NMR(500MHz,DMSO-d6)δ8.21(d,J=5.3Hz,1H),8.01(d,J=8.3Hz,2H),7.87(d,J=8.3Hz,2H),7.84–7.75(m,4H),7.70–7.64(m,3H),7.29(dd,J=8.5,5.5Hz,2H),7.20(t,J=8.8Hz,2H),6.87(t,J=8.7Hz,2H),4.49(dd,J=13.2,5.8Hz,1H),3.88(s,3H),3.83(s,3H),3.57(d,J=13.0Hz,1H).13C NMR(125MHz,DMSO-d6)δ166.14,163.27(d,J=247.9Hz),161.74(d,J=243.5Hz),151.83,141.42,135.97,135.04,132.97,131.54,130.39,129.99,129.52,129.17(d,J=21.0Hz),128.55,128.48,127.29,126.94,126.72,126.65,116.55,115.84(d,J=21.4Hz),115.18(d,J=21.8Hz),101.45,52.73,52.47,43.86.HRMS(ESI)m/z calcd for C34H26F2N4NaO2 +(M+Na)+647.1718,found 647.1716.
example 10
1a in example 6 was replaced with 1g, and the experimental results were shown in Table 1, under the same conditions as in example 1.
Figure BDA0001801644990000101
Spectrogram analysis data 3gb:
1H NMR(500MHz,DMSO-d6)δ8.12(d,J=5.8Hz,1H),7.91(d,J=8.0Hz,2H),7.85–7.77(m,5H),7.69(dd,J=21.6,7.6Hz,4H),7.60(t,J=6.0Hz,4H),7.49(q,J=8.1Hz,4H),7.40(dt,J=14.1,7.3Hz,2H),7.29–7.21(m,4H),6.81(t,J=8.6Hz,2H),4.48(dd,J=13.2,5.8Hz,1H),3.64(d,J=12.9Hz,1H).13C NMR(125MHz,DMSO-d6)δ163.17(d,J=247.2Hz),161.63(d,J=243.3Hz),152.57,142.52,142.15,140.28,140.02,139.65,134.51,130.86,130.72,129.91,129.41,128.45,128.35,128.04,127.95,127.35,127.18,127.09,127.00,126.60,126.51,116.23,115.84(d,J=21.4Hz),114.94(d,J=21.5Hz),101.09,44.08.HRMS(ESI)m/z calcd for C42H31F2N4O2 +(M+H)+661.2415,found 661.2425.
TABLE 1
Figure BDA0001801644990000111

Claims (2)

1. A process for the preparation of a polysubstituted oxadiazine derivative having the structure shown in formula i:
Figure FDA0002893097590000011
R1the substituent group is selected from fluorine, chlorine, bromine, iodine, carbomethoxy and phenyl; r2The substituent group is selected from fluorine, chlorine and bromine; it is characterized in that substituted benzamidoxime, substituted phenylethynyl iodonium salt and KOH are added into a reactor and stirred in tetrahydrofuran at room temperatureStirring for 4 hours, after the reaction is finished, concentrating by using a rotary evaporator to obtain a crude product, and separating the crude product by using silica gel column chromatography to obtain a compound shown as a formula I, wherein the chemical process is shown as a reaction formula II:
Figure FDA0002893097590000012
2. the method of claim 1, wherein: the molar ratio of the substituted benzamidoxime to the substituted phenylethynyl iodonium salt to the potassium hydroxide is 1:1.2: 1.5.
CN201811079843.XA 2018-09-17 2018-09-17 Preparation method of polysubstituted oxadiazine derivative Active CN108947995B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811079843.XA CN108947995B (en) 2018-09-17 2018-09-17 Preparation method of polysubstituted oxadiazine derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811079843.XA CN108947995B (en) 2018-09-17 2018-09-17 Preparation method of polysubstituted oxadiazine derivative

Publications (2)

Publication Number Publication Date
CN108947995A CN108947995A (en) 2018-12-07
CN108947995B true CN108947995B (en) 2021-03-16

Family

ID=64476862

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811079843.XA Active CN108947995B (en) 2018-09-17 2018-09-17 Preparation method of polysubstituted oxadiazine derivative

Country Status (1)

Country Link
CN (1) CN108947995B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109851599B (en) * 2019-03-19 2022-03-08 青岛科技大学 Preparation method of 2-aminobenzofuran compound

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104327008A (en) * 2014-10-30 2015-02-04 湖南大学 Synthesis method of benzoxazole compound
CN107629020A (en) * 2017-09-28 2018-01-26 湖北科技学院 A kind of (6H) ketone compounds of 1,2,4 oxadiazines of 4H 5 and its synthetic method
CN108314658A (en) * 2018-04-12 2018-07-24 青岛科技大学 A kind of preparation method of Duo substituted oxazoles derivative

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104327008A (en) * 2014-10-30 2015-02-04 湖南大学 Synthesis method of benzoxazole compound
CN107629020A (en) * 2017-09-28 2018-01-26 湖北科技学院 A kind of (6H) ketone compounds of 1,2,4 oxadiazines of 4H 5 and its synthetic method
CN108314658A (en) * 2018-04-12 2018-07-24 青岛科技大学 A kind of preparation method of Duo substituted oxazoles derivative

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
One Base for Two Shots: Metal-Free Substituent-Controlled Synthesis of Two Kinds of Oxadiazine Derivatives from Alkynylbenziodoxolones and Amidoximes;Ming Li,等;《The Journal of Organic Chemistry》;20190514;第84卷;第6904-6915页 *

Also Published As

Publication number Publication date
CN108947995A (en) 2018-12-07

Similar Documents

Publication Publication Date Title
CN108314658B (en) A kind of preparation method of polysubstituted oxazole derivatives
CN108947995B (en) Preparation method of polysubstituted oxadiazine derivative
CN113788766A (en) Preparation method of atorvastatin calcium intermediate
CN111072588B (en) Preparation method of sulfur-containing cyano thiazoline compound
CN113881956A (en) Preparation method of benzyl isocyanate compound
CN111235596A (en) Preparation method of thiazoline compound containing selenium
CN113045385B (en) Method for synthesizing aliphatic pinacol
CN111704591B (en) Synthesis method of copper-catalyzed thionaphthothiazolone compound
CN111362795B (en) Preparation method of substituted butyrate derivatives
CN109851599B (en) Preparation method of 2-aminobenzofuran compound
CN114478245A (en) Asymmetric synthesis method of chiral gamma-alkynyl-alpha-keto acid ester compound
CN109678862B (en) Preparation method of polysubstituted distyryl indole derivative
EP4269387A1 (en) Pyrrolinone compound and synthesis method therefor
CN111499600A (en) Synthesis method of polysubstituted 2, 3-dihydrofuran compound
CN114411182B (en) Method for synthesizing alpha-carbonyl sulfoxide ylide dichlorides under electrocatalytic action
CN116535363B (en) Synthesis method of isoxazolidine derivative constructed by three-component cycloaddition with participation of iodoylide
CN111039844A (en) Polysubstituted arylpyrrole compounds
CN115322106B (en) Synthesis method of trans-3-azido-1-methylcyclobutanol and trans-3-amino-1-methylcyclobutanol
CN114214651B (en) Method for synthesizing alpha-carbonyl-alpha' -thiocyano sulfoxide ylide under electrocatalytic action
CN117143066A (en) Synthesis method of selenylbenzoxepin compound
CN115433097B (en) Method for preparing 4-butoxybenzoic acid (2-diethylaminoethyl) ester without metal
CN111484476B (en) 3-hydro-1, 2-dithio-2, 2-dioxide and preparation method thereof
CN111825594B (en) (Z) -beta-trifluoromethyl dehydrotryptophan compound and synthetic method and application thereof
CN108530381B (en) Method for preparing diamine derivative from amide ester
CN115746020A (en) Preparation of novel tetra-cyclic compounds without metal

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20240105

Address after: 256600 south side of xinyongxin Road, Binbei office, Bincheng District, Binzhou City, Shandong Province

Patentee after: Shoujian Technology Co.,Ltd.

Address before: No. 53, Zhengzhou Road, North District, Qingdao, Shandong

Patentee before: QINGDAO University OF SCIENCE AND TECHNOLOGY